MDxHealth
De berekende faillissementskans van MDxHealth over 12 maanden bedraagt 0,3% (zeer laag). Het bedrijf is actief sinds 2003 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 23 jaar |
| Bestuur | 29 |
| Vestigingen | 1 |
| Publicaties | 183 |
Statistische inschatting op basis van openbare bronnen — geen kredietadvies of vaststelling. Hoe berekenen we dit?
| Boekjaar | Type | Neerlegging | Referentie |
|---|---|---|---|
| 31-12-2024 | volledig | 17-06-2025 | 2025-00165763 |
| 31-12-2024 | consolidatie | 23-06-2025 | 2025-00176731 |
| 31-12-2023 | volledig | 20-06-2024 | 2024-00150440 |
| 31-12-2023 | consolidatie | 21-06-2024 | 2024-00172915 |
| 31-12-2022 | volledig | 30-05-2023 | 2023-00105403 |
| 31-12-2022 | consolidatie | 20-12-2023 | 2023-00534027 |
| 31-12-2021 | volledig | 30-05-2022 | 2022-20050027 |
| 31-12-2021 | consolidatie | 20-12-2023 | 2023-00534270 |
| 31-12-2020 | volledig | 27-05-2021 | 2021-16200352 |
| 31-12-2019 | volledig | 29-05-2020 | 2020-14200381 |
-
Actief06-10-2025 → heden
-
Qaly-Co SàrlRechtspersoonBestuurder· vast vert.: Lieve VerplanckeStaatsblad-akte 24138708 (25-09-2024)Actief25-09-2024 → heden
2 gebeurtenissen
- 25-09-2024 Mandaat verlengd· Bestuurder
- 07-07-2024 Ontslagen· Bestuurder
-
Actief06-07-2024 → heden
2 gebeurtenissen
- 06-10-2025 Mandaat verlengd· Bestuurder
- 06-07-2024 Benoemd· Bestuurder
-
Actief29-09-2021 → heden
2 gebeurtenissen
- 06-10-2025 Mandaat verlengd· Bestuurder
- 29-09-2021 Benoemd· Bestuurder
-
Ahok BVRechtspersoonBestuurder· vast vert.: Koen HoffmanStaatsblad-akte 24138708 (25-09-2024)Actief07-07-2021 → heden
2 gebeurtenissen
- 25-09-2024 Mandaat verlengd· Bestuurder
- 07-07-2021 Mandaat verlengd· Bestuurder
-
Qaly-Co BVRechtspersoonBestuurder· vast vert.: Lieve VerplanckeStaatsblad-akte 21342246 (07-07-2021)Actief07-07-2021 → heden
-
RR-Invest S.à.r.l.RechtspersoonBestuurder· vast vert.: Rudi MariënStaatsblad-akte 21342246 (07-07-2021)Actief07-07-2021 → heden
-
Actief18-08-2020 → heden
3 gebeurtenissen
- 06-10-2025 Mandaat verlengd· Bestuurder
- 22-08-2023 Mandaat verlengd· Bestuurder
- 18-08-2020 Benoemd· Bestuurder
-
Hilde Windels BVRechtspersoonBestuurder· vast vert.: Hilde WindelsStaatsblad-akte 25125923 (06-10-2025)Actief16-06-2020 → heden
3 gebeurtenissen
- 06-10-2025 Mandaat verlengd· Bestuurder
- 22-08-2023 Mandaat verlengd· Bestuurder
- 16-06-2020 Mandaat verlengd· Bestuurder
-
Actief19-03-2019 → heden
2 gebeurtenissen
- 22-08-2023 Mandaat verlengd· Bestuurder
- 19-03-2019 Benoemd· Bestuurder
-
Ahok SPRLRechtspersoonBestuurder· vast vert.: Koen HoffmanStaatsblad-akte 18146138 (03-10-2018)Actief03-10-2018 → heden
-
Hilde Windels SPRLRechtspersoonBestuurder· vast vert.: Hilde WindelsStaatsblad-akte 18146138 (03-10-2018)Actief03-10-2018 → heden
-
Qaly-Co BVBARechtspersoonBestuurder· vast vert.: Dr. Lieve VerplanckeStaatsblad-akte 18037121 (26-02-2018)Actief26-02-2018 → heden
-
Hilde Windels BVBARechtspersoonBestuurder· vast vert.: Hilde WindelsStaatsblad-akte 18037121 (26-02-2018)Actief27-10-2017 → heden
-
Hasseltberg BVBARechtspersoonBestuurder· vast vert.: Ruth DevenynsStaatsblad-akte 16157684 (17-11-2016)Actief27-05-2016 → heden
-
Shaffar LLCRechtspersoonBestuurder· vast vert.: Mark ShaffarStaatsblad-akte 16157684 (17-11-2016)Actief27-05-2016 → heden
2 gebeurtenissen
- 03-10-2018 Ontslagen· Bestuurder
- 27-05-2016 Benoemd· Bestuurder
-
LabDx L.L.C.RechtspersoonBestuurder· vast vert.: Walter NarajowskiStaatsblad-akte 16157684 (17-11-2016)Actief03-10-2015 → heden
2 gebeurtenissen
- 27-05-2016 Mandaat verlengd· Bestuurder
- 03-10-2015 Benoemd· Bestuurder
-
Valetusan Ltd.RechtspersoonBestuurder· vast vert.: Dr. Rudi PauwelsStaatsblad-akte 14209945 (20-11-2014)Actief31-07-2014 → heden
-
Actief01-07-2014 → heden
-
Greenlands Consulting LLCRechtspersoonBestuurder· vast vert.: Edward EricksonStaatsblad-akte 13102909 (05-07-2013)Actief05-07-2013 → heden
-
Gengest BVBARechtspersoonBestuurder· vast vert.: Rudi MariënStaatsblad-akte 18037121 (26-02-2018)Actief21-11-2012 → heden
3 gebeurtenissen
- 26-02-2018 Mandaat verlengd· Bestuurder
- 05-07-2013 Mandaat verlengd· Bestuurder
- 21-11-2012 Benoemd· Bestuurder
-
Actief21-11-2012 → heden
2 gebeurtenissen
- 29-05-2015 Mandaat verlengd· Bestuurder
- 21-11-2012 Benoemd· Bestuurder
-
Actief22-07-2008 → heden
-
Actief22-07-2008 → heden
-
Actief22-07-2008 → heden
-
Actief22-07-2008 → heden
-
Herman Spolders BVBARechtspersoonZaakvoerder· vast vert.: Herman SpoldersStaatsblad-akte 08121255 (22-07-2008)Actief22-07-2008 → heden
-
ING Belgium NV/SARechtspersoonBestuurder· vast vert.: Denis Biju-DuvalStaatsblad-akte 08121255 (22-07-2008)Actief22-07-2008 → heden
-
Sogam SARechtspersoonBestuurder· vast vert.: Alain ParthoensStaatsblad-akte 08121255 (22-07-2008)Actief22-07-2008 → heden
Voormalige bestuurders (12)
-
REGINE SLAGMULDER BVRechtspersoonBestuurder· vast vert.: Regine SlagmulderStaatsblad-akte 23382557 (22-08-2023)Voormalig18-08-2020 → 28-05-2025
3 gebeurtenissen
- 28-05-2025 Ontslagen· Bestuurder
- 22-08-2023 Mandaat verlengd· Bestuurder
- 18-08-2020 Benoemd· Bestuurder
-
Valiance Advisors LLPRechtspersoonBestuurder· vast vert.: Jan PensaertStaatsblad-akte 21342246 (07-07-2021)Voormalig20-11-2014 → 15-02-2024
4 gebeurtenissen
- 15-02-2024 Ontslagen· Bestuurder
- 07-07-2021 Mandaat verlengd· Bestuurder
- 03-10-2018 Mandaat verlengd· Bestuurder
- 20-11-2014 Benoemd· Bestuurder
-
TSTILL ENTERPRISES LLCRechtspersoonBestuurder· vast vert.: Timothy StillStaatsblad-akte 20326527 (16-06-2020)Voormalig16-06-2020 → 28-07-2021
2 gebeurtenissen
- 28-07-2021 Ontslagen· Bestuurder
- 16-06-2020 Benoemd· Bestuurder
-
Voormalig05-07-2013 → 18-02-2019
3 gebeurtenissen
- 18-02-2019 Ontslagen· Bestuurder
- 26-02-2018 Mandaat verlengd· Bestuurder
- 05-07-2013 Mandaat verlengd· Bestuurder
-
Shaffar LCCRechtspersoonBestuurder· vast vert.: Mark ShaffarStaatsblad-akte 18037121 (26-02-2018)Voormalig— → 19-10-2017
-
Greeniands Consulting LLCRechtspersoonBestuurder· vast vert.: Edward EricksonStaatsblad-akte 16157684 (17-11-2016)Voormalig— → 30-06-2016
-
LaurelWey Consulting LLCRechtspersoonBestuurder· vast vert.: Mark MyslinskiStaatsblad-akte 15086754 (19-06-2015)Voormalig29-05-2015 → 02-10-2015
2 gebeurtenissen
- 02-10-2015 Ontslagen· Bestuurder
- 29-05-2015 Benoemd· Bestuurder
-
Voormalig05-07-2013 → 29-05-2015
2 gebeurtenissen
- 29-05-2015 Ontslagen· Bestuurder
- 05-07-2013 Mandaat verlengd· Bestuurder
-
Quaestor Management Services Ltd.RechtspersoonBestuurder· vast vert.: Dr. Rudi PauwelsStaatsblad-akte 14126536 (01-07-2014)Voormalig30-05-2014 → 01-07-2014
2 gebeurtenissen
- 01-07-2014 Ontslagen· Bestuurder
- 30-05-2014 Benoemd· Bestuurder
-
Voormalig05-07-2013 → 30-05-2014
2 gebeurtenissen
- 30-05-2014 Ontslagen· Bestuurder
- 05-07-2013 Benoemd· Bestuurder
-
Edmond de Rothschild Investment PartnersRechtspersoonBestuurder· vast vert.: Raphaël WisniewskiStaatsblad-akte 08121255 (22-07-2008)Voormalig22-07-2008 → 05-07-2013
2 gebeurtenissen
- 05-07-2013 Ontslagen· Bestuurder
- 22-07-2008 Mandaat verlengd· Bestuurder
-
ING Belgium NVRechtspersoonBestuurder· vast vert.: Denis Biju-DuvalStaatsblad-akte 12188064 (21-11-2012)Voormalig— → 21-11-2012
| Commissaris / bedrijfsrevisor | IBR/IRE-nummer | Periode |
|---|---|---|
| BDO Réviseurs d'Entreprises CVBAActief Commissaris · vertegenwoordigd door Bert Kegels |
— | 16-06-2020 → heden |
| BDO Réviseurs d'Entreprises SRLActief Commissaris · vertegenwoordigd door Bert Kegels |
— | 22-08-2023 → heden |
| Michael K. McGarrityActief Commissaris |
— | 20-02-2023 → heden |
| Soc. Civ. SCRL BDO Réviseurs d'EntreprisesActief Commissaris · vertegenwoordigd door Gert Claes |
— | 21-11-2012 → heden |
| NACE primair | 72101 |
| Rechtsvorm | NV(014) |
| Oprichtingsdatum | 15-01-2003 |
| Status | Actief |
| Postcode | 4040 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is — geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 62312A0453/00W002 | Wallonië | 7.839 m² | 1 · 828 m² | — |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd — publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
22-10-2025 Kapitaalverhoging van €3.866.208,91 tot €208.111.701,01
- €204.245.492,10 → €208.111.701,01
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 3866208.91,
"currency": "EUR",
"after_eur": 208111701.01,
"delta_eur": 3866208.91,
"before_eur": 204245492.1,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-10-01",
"evidence_quote": "le conseil d\u0027administration d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9, dans le cadre du capital autoris\u00E9 tel que d\u00E9crit \u00E0 l\u0027article 6 des statuts de la Soci\u00E9t\u00E9, d\u0027un montant de trois millions huit cent soixante-six mille deux cent huit euros et nonante-et-un cents (EUR 3.866.208,91) ... en r\u00E9mun\u00E9ration de l\u0027apport en nature par Bio-Techne de la Cr\u00E9ance Apport\u00E9e \u00E0 la Soci\u00E9t\u00E9.",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDXHEALTH, EN ABREGE : MDXH",
"legal_form": "SA"
}
}22-10-2025 Kapitaalverhoging van €3.866.208,91 tot €208.111.701,01
- €204.245.492,10 → €208.111.701,01
- Inbreng in natura · Apport en nature
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 208111701.01,
"delta_eur": 3866208.9099999964,
"before_eur": 204245492.1,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDxHealth"
}
}22-10-2025 Kapitaalverhoging van €3.866.208,91
- Inbreng in natura · Apport en nature
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": 3866208.91,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Bio-Techne",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": "natura",
"n_shares_subscribed": 1867186,
"contribution_amount_eur": 3866208.91
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 1867186,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 2.07
},
"decrease_purpose": null,
"contribution_type": "natura",
"paid_up_delta_eur": 3866208.91,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_distributable"
},
{
"kind": "share_split",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "other",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "other",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-10-22",
"filing_date": "2025-10-20",
"act_kind_objet": "CAPITAL, ACTIONS"
},
"decision": {
"body": "raad_van_bestuur",
"act_date": "2025-10-01",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDxHealth",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition du proc\u00E8s-verbal",
"procurations",
"rapport du conseil d\u0027administration",
"rapport du commissaire \u00E0 l\u0027organe d\u0027administrations",
"statuts coordonn\u00E9s"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 51364520,
"class_name": "Gewone Aandelen",
"capital_share_eur": 208111701.01,
"voting_rights_per_share": 1.0
}
]
}06-10-2025 2 bestuurders benoemd, 1 ontslagnemend
- Dr. Sanford Jay Siegel — Bestuurder
- Michael Brian Holder — Bestuurder
- Regine Slagmulder — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Regine Slagmulder",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Dr. Sanford Jay Siegel",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Michael Brian Holder",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDxHealth"
}
}06-10-2025 2 bestuurders benoemd, 1 ontslagnemend, 3 herbenoemd
- Dr. Sanford Jay Siegel — Bestuurder
- Michael Brian Holder — Bestuurder
- Regine Slagmulder — Bestuurder
- Donnie M. Hardison Jr. — Bestuurder
- Hilde Windels — Bestuurder
- Eric Bednarski — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Regine Slagmulder",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "end_of_term",
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": "2025-05-28",
"evidence_quote": "le mandat de Regine Slagmulder BV, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Regine Slagmulder, en tant qu\u0027administrateur de la soci\u00E9t\u00E9 MDxHealth SA, n\u0027est pas renouvel\u00E9 et prend fin avec effet au 28 mai 2025",
"decharge_status": null,
"mandate_duration": {
"kind": "until_date",
"value": "2025-05-28"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Dr. Sanford Jay Siegel",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "confirmation",
"via_org": null,
"statutory": "coopted",
"compensated": true,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires d\u00E9cide de confirmer la nomination par cooptation, suite \u00E0 la d\u00E9mission de Qaly-Co S\u00E0rl, de Dr. Sanford Jay Siegel en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, pour une dur\u00E9e s\u0027\u00E9tendant jusqu\u0027\u00E0, et y compris, la cl\u00F4ture de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnai",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2026"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_renew",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Donnie M. Hardison Jr.",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": null,
"statutory": "statutair",
"compensated": true,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires d\u00E9cide de renouveler le mandat de Donnie M. Hardison Jr. en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, pour une dur\u00E9e de deux ans, s\u0027\u00E9tendant jusqu\u0027\u00E0, et y compris, la cl\u00F4ture de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires \u00E0 tenir en 2027 qui statuera sur les com",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": 2
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_renew",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Hilde Windels",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": null,
"name": "Hilde Windels BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": "statutair",
"compensated": true,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires d\u00E9cide de renouveler le mandat de Hilde Windels BV, repr\u00E9sent\u00E9e par Hilde Windels en tant que repr\u00E9sentante permanente, en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, pour une dur\u00E9e de deux ans, s\u0027\u00E9tendant jusqu\u0027\u00E0, et y compris, la cl\u00F4ture de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordi",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": 2
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_renew",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Eric Bednarski",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": null,
"statutory": "statutair",
"compensated": true,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires d\u00E9cide de renouveler le mandat de Eric Bednarski en tant qu\u0027administrateur de. la Soci\u00E9t\u00E9, pour une dur\u00E9e de deux ans, s\u0027\u00E9tendant jusqu\u0027\u00E0, et y compris, la cl\u00F4ture de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires \u00E0 tenir en 2027 qui statuera sur. les comptes a",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": 2
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Michael Brian Holder",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": true,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires d\u00E9cide de nommer Michael Brian Holder en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, pour une dur\u00E9e de deux ans, s\u0027\u00E9tendant jusqu\u0027\u00E0, et y compris, la cl\u00F4ture de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires \u00E0 tenir en 2027 qui statuera sur. les comptes annuels de l\u0027",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": 2
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-10-06",
"filing_date": "2025-09-26",
"act_kind_objet": "Confirmation de nomination - renouvellement de mandats - nomination d\u0027un administrateur"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2025-05-28",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDxHealth",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Michael McGarrity",
"org_rep_person_name": null,
"person_role_at_subject": "Administrateur d\u00E9l\u00E9gu\u00E9"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}06-10-2025 1 bestuurder benoemd, 1 ontslagnemend, 4 herbenoemd
- Michael Brian Holder — Bestuurder
- Regine Slagmulder — Bestuurder
- Dr. Sanford Jay Siegel — Bestuurder
- Donnie M. Hardison Jr. — Bestuurder
- Hilde Windels — Bestuurder
- Eric Bednarski — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Regine Slagmulder",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Regine Slagmulder BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-05-28",
"evidence_quote": "Suite aux d\u00E9cisions prises par l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire le 28 mai 2025 (extrait ci-dessous), le mandat de Regine Slagmulder BV, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Regine Slagmulder, en tant qu\u0027administrateur de la soci\u00E9t\u00E9 MDxHealth SA, n\u0027est pas renouvel\u00E9 et prend fin avec effet au 28 "
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Dr. Sanford Jay Siegel",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires d\u00E9cide de confirmer la nomination par cooptation, suite \u00E0 la d\u00E9mission de Qaly-Co S\u00E0rl, de Dr. Sanford Jay Siegel en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, pour une dur\u00E9e s\u0027\u00E9tendant jusqu\u0027\u00E0, et y compris, la cl\u00F4ture de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnai"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Donnie M. Hardison Jr.",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires d\u00E9cide de renouveler le mandat de Donnie M. Hardison Jr. en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, pour une dur\u00E9e de deux ans, s\u0027\u00E9tendant jusqu\u0027\u00E0, et y compris, la cl\u00F4ture de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires \u00E0 tenir en 2027 qui statuera sur les com"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Hilde Windels",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Hilde Windels BV",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires d\u00E9cide de renouveler le mandat de Hilde Windels BV, repr\u00E9sent\u00E9e par Hilde Windels en tant que repr\u00E9sentante permanente, en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, pour une dur\u00E9e de deux ans, s\u0027\u00E9tendant jusqu\u0027\u00E0, et y compris, la cl\u00F4ture de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordi"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Eric Bednarski",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires d\u00E9cide de renouveler le mandat de Eric Bednarski en tant qu\u0027administrateur de. la Soci\u00E9t\u00E9, pour une dur\u00E9e de deux ans, s\u0027\u00E9tendant jusqu\u0027\u00E0, y compris, la cl\u00F4ture de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires \u00E0 tenir en 2027 qui statuera sur les comptes annue"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Michael Brian Holder",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires d\u00E9cide de nommer Michael Brian Holder en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, pour une dur\u00E9e de deux ans, et y compris, la cl\u00F4ture de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires \u00E0 tenir en 2027 qui statuera sur les comptes annuels de l\u0027exercice social cl\u00F4tu"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDXHEALTH, EN ABREGE : MDXH",
"legal_form": "SA"
}
}25-07-2025 Publicatie in het Belgisch Staatsblad — Diversen
Technische details
{
"stage": null,
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-07-25",
"filing_date": "2025-07-23",
"act_kind_objet": "DIVERS"
},
"decision": {
"body": "algemene_vergadering",
"act_date": null,
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0479.292.440",
"name": "MDxHealth",
"role": "other",
"address": "Rue d\u0027Abhooz 31, 4040 Herstal",
"is_foreign": false,
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": null,
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDxHealth",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Stijn RAES",
"org_rep_person_name": null
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la soci\u00E9t\u00E9 anonyme MDxHealth a pris des r\u00E9solutions concernant la communication des rapports et la proposition d\u0027\u00E9mettre 3.500.000 options d\u0027action pour 2025, en supprimant le droit de pr\u00E9f\u00E9rence des actionnaires existants.",
"co_filed_documents": [
"exp\u00E9dition de l\u0027acte",
"liste de pr\u00E9sence",
"registre des votes",
"rapport du conseil d\u0027administration conform\u00E9ment aux articles 7:180 et 7:191 du Code des soci\u00E9t\u00E9s et associations",
"rapport du commissaire conform\u00E9ment aux articles 7:180 et 7:191 du Code des soci\u00E9t\u00E9s et associations",
"statuts coordonn\u00E9s"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "statutes"
}25-07-2025 Publicatie in het Belgisch Staatsblad — Diversen
Technische details
{
"stage": null,
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2025-07-25",
"filing_date": "2025-07-23",
"act_kind_objet": "DIVERS"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-06-27",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0479.292.440",
"name": "MDxHealth",
"role": "other",
"address": "Rue d\u0027Abhooz 31, 4040 Herstal",
"is_foreign": false,
"legal_form": "SA",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"7:180",
"7:191"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 3500000,
"real_estate_included": false,
"patrimony_description": "\u00C9mission de 3.500.000 options sur actions (2025 Share Options) sans droit de pr\u00E9f\u00E9rence pour les actionnaires existants, destin\u00E9es \u00E0 \u00EAtre attribu\u00E9es \u00E0 des participants s\u00E9lectionn\u00E9s.",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDxHealth",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Stijn RAES",
"org_rep_person_name": null
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la soci\u00E9t\u00E9 anonyme MDxHealth, si\u00E9geant \u00E0 Herstal, a approuv\u00E9 l\u0027\u00E9mission de 3.500.000 options sur actions (2025 Share Options) conform\u00E9ment \u00E0 un plan d\u0027option sur action. Le droit de pr\u00E9f\u00E9rence des actionnaires existants et des d\u00E9tenteurs de droits de souscription en circulation a \u00E9t\u00E9 supprim\u00E9 en faveur des participants s\u00E9lectionn\u00E9s.",
"co_filed_documents": [
"exp\u00E9dition de l\u0027acte",
"liste de pr\u00E9sence",
"registre des votes",
"rapport du conseil d\u0027administration conform\u00E9ment aux articles 7:180 et 7:191 du Code des soci\u00E9t\u00E9s et associations",
"rapport du commissaire conform\u00E9ment aux articles 7:180 et 7:191 du Code des soci\u00E9t\u00E9s et associations",
"statuts coordonn\u00E9s - d\u00E9pos\u00E9s dans la banque de donn\u00E9es \u00E9lectronique des Statuts de FedNot"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "capital_shares"
}13-11-2024 Kapitaalverhoging van €4.084.379,73 tot €204.245.492,10
- €200.161.112,37 → €204.245.492,10
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 4084379.73,
"currency": "EUR",
"after_eur": 204245492.1,
"delta_eur": 4084379.73,
"before_eur": 200161112.37,
"amount_type": "kapitaal_effectief",
"effective_date": "2024-10-29",
"evidence_quote": "l\u0027augmentation du capital est ainsi effectivement r\u00E9alis\u00E9e pour un montant de quatre millions quatre-vingt-quatre mille trois cent septante-neuf euros septante-trois cents (EUR 4.084.379,73)",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDXHEALTH, EN ABREGE : MDXH",
"legal_form": "SA"
}
}13-11-2024 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDxHealth"
},
"legal_form_change": {
"new": "Soci\u00E9t\u00E9 anonyme",
"old": "Soci\u00E9t\u00E9 anonyme",
"changed": false
}
}13-11-2024 Kapitaalverhoging van €4.084.379,73 tot €208.329.871,83
- €204.245.492,10 → €208.329.871,83
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 208329871.83,
"delta_eur": 4084379.73,
"before_eur": 204245492.1,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "TD Securities (USA) LLC",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 2209241,
"contribution_amount_eur": 4084379.73
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 2209241,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 1.84
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": 4084379.73,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "reserves_incorporation",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_distributable"
}
],
"notary": {
"name": "Emmanuelle VAN HAMME",
"firm_city": null,
"firm_name": "Raes Van Hamme Notarissen",
"office_city": "Gent",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2024-11-13",
"filing_date": "2024-11-08",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "conseil_d\u0027administration",
"act_date": "2024-10-29",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": "2024-09-24"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDxHealth",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": true
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Stijn RAES",
"org_rep_person_name": null,
"person_role_at_subject": "Notaire"
},
"co_filed_documents": [
"exp\u00E9dition de l\u0027acte",
"d\u00E9cisions du comit\u00E9 de placement",
"souscription",
"statuts coordonn\u00E9s"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 49497334,
"class_name": "actions sans valeur nominale",
"capital_share_eur": 208329871.83,
"voting_rights_per_share": 1.0
}
]
}13-11-2024 Kapitaalverhoging van €4.084.379,73 tot €204.245.492,10
- €200.161.112,37 → €204.245.492,10
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 204245492.1,
"delta_eur": 4084379.7299999893,
"before_eur": 200161112.37,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDxHealth"
}
}13-11-2024 Statutenwijziging — vertaling van de statuten, coördinatie van de statuten en volledige herziening van de statuten
Technische details
{
"notary": {
"name": "Emmanuelle VAN HAMME",
"firm_city": null,
"firm_name": "Raes Van Hamme Notarissen",
"office_city": "Gent",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2024-11-13",
"filing_date": "2024-11-08",
"act_kind_objet": "CAPITAL, ACTIONS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS)"
},
"decision": {
"body": "conseil_d\u0027administration",
"act_date": "2024-10-24",
"unanimous": null
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"full_restatement",
"targeted_amendment"
],
"scope": "full_restatement",
"trigger": "capital_change_consequence",
"language_after": "fr",
"language_before": "fr"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0479.292.440",
"name_full_after": "MDxHealth",
"legal_form_after": "Soci\u00E9t\u00E9 anonyme",
"name_full_before": "MDxHealth",
"current_zetel_raw": "Rue d\u0027Abhooz 31, 4040 Herstal",
"legal_form_before": "Soci\u00E9t\u00E9 anonyme"
},
"special_mandates": [
{
"holder_kbo": null,
"holder_name": "TD Securities (USA) LLC",
"scope_categories": [
"kbo"
],
"with_substitution": null
}
],
"articles_modified": [
{
"summary": "Le capital est fix\u00E9 \u00E0 204.245.492,10 EUR, divis\u00E9 en 49.497.334 actions sans valeur nominale, enti\u00E8rement souscrit et lib\u00E9r\u00E9.",
"new_text": "Le capital s\u0027\u00E9l\u00E8ve \u00E0 deux cent quatre millions deux cent quarante-cinq mille quatre cent nonante-deux euros dix cents (EUR 204.245.492,10). Il est divis\u00E9 en quarante-neuf millions quatre cent nonante-sept mille trois cent trente-quatre (49.497.334) actions sans valeur nominale, chacune repr\u00E9sentant la m\u00EAme fraction du capital. Le capital est enti\u00E8rement et inconditionnellement souscrit et est enti",
"change_kind": "replaced",
"article_title": null,
"article_number": "5.1"
},
{
"summary": "Ajout d\u0027une clause de r\u00E9f\u00E9rence \u00E0 l\u0027acte notari\u00E9 du 29 octobre 2024 confirmant la r\u00E9alisation de l\u0027augmentation de capital.",
"new_text": "Aux termes de l\u0027acte re\u00E7u par le notaire Emmanuelle Van Hamme, notaire de r\u00E9sidence \u00E0 Gent, le 29 octobre 2024, il a \u00E9t\u00E9 constat\u00E9 que l\u0027augmentation du capital, dans le cadre du capital autoris\u00E9, d\u00E9cid\u00E9e par le conseil d\u0027administration du 24 septembre 2024, a \u00E9t\u00E9 r\u00E9alis\u00E9e \u00E0 concurrence de quatre millions quatre-vingt-quatre mille trois cent septante-neuf euros septante-trois cents (EUR 4.084.379,7",
"change_kind": "added",
"article_title": null,
"article_number": "5.2"
}
],
"governance_change": null,
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Stijn RAES",
"org_rep_person_name": null
},
"co_filed_documents": [
"exp\u00E9dition de l\u0027acte",
"d\u00E9cisions du comit\u00E9 de placement",
"souscription",
"statuts coordonn\u00E9s"
],
"shareholder_rights": null,
"voorwerp_change_summary": null,
"capital_structure_change": {
"operations": [
"capital_increase_cash",
"share_class_creation"
],
"split_ratio": null,
"shares_after": 49497334,
"shares_before": null,
"capital_after_eur": 204245492.1,
"capital_before_eur": null,
"share_classes_after": [
{
"count": 49497334,
"label": "actions sans valeur nominale",
"rights_summary": "Repr\u00E9sentent la m\u00EAme fraction du capital.",
"voting_per_share": null
}
]
},
"coordinated_text_lineage": null
}13-11-2024 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2024-10-29",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDXHEALTH, EN ABREGE : MDXH",
"legal_form": "SA"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}18-10-2024 Kapitaalverhoging van €35.858.359,48 tot €200.161.112,37
- €164.302.752,89 → €200.161.112,37
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 35858359.48,
"currency": "EUR",
"after_eur": 200161112.37,
"delta_eur": 35858359.48,
"before_eur": 164302752.89,
"amount_type": "kapitaal_effectief",
"effective_date": "2024-09-27",
"evidence_quote": "l\u0027augmentation du capital est ainsi effectivement r\u00E9alis\u00E9e pour un montant de trente-cinq millions huit cent cinquante-huit mille trois cent cinquante-neuf euros quarante-huit cents (EUR 35.858.359,48)",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDXHEALTH, EN ABREGE : MDXH",
"legal_form": "SA"
}
}18-10-2024 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2024-09-27",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDXHEALTH, EN ABREGE : MDXH",
"legal_form": "SA"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}18-10-2024 Kapitaalverhoging van €35.858.359,48 tot €200.161.112,37
- €164.302.752,89 → €200.161.112,37
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 200161112.37,
"delta_eur": 35858359.48000002,
"before_eur": 164302752.89,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDxHealth"
}
}18-10-2024 Kapitaalverhoging van €35.858.359,48 tot €200.161.112,37
- €164.302.752,89 → €200.161.112,37
Technische details
{
"events": [
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "TD Securities (USA) LLC",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 18500000,
"contribution_amount_eur": 33168982.52
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Genomic Health, Inc.",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 1500000,
"contribution_amount_eur": 2689376.96
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 20000000,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 1.79
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 200161112.37,
"delta_eur": 35858359.48,
"before_eur": 164302752.89,
"_arith_derived": "before",
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 20000000,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 1.79
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": 35858359.48,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": "Raes Van Hamme Notarissen",
"office_city": "Gent",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2024-10-18",
"filing_date": "2024-10-16",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "conseil_d\u0027administration",
"act_date": "2024-09-27",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": "2024-09-24"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDxHealth",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": true
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition de l\u0027acte",
"souscription",
"sousciription",
"statuts coordonn\u00E9s"
],
"shareholders_after": [],
"share_classes_after": []
}18-10-2024 Statutenwijziging — vertaling van de statuten, coördinatie van de statuten en volledige herziening van de statuten
Technische details
{
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": "Raes Van Hamme Notarissen",
"office_city": "Gent",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2024-10-18",
"filing_date": "2024-10-16",
"act_kind_objet": "CAPITAL, ACTIONS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS)"
},
"decision": {
"body": "conseil_d\u0027administration",
"act_date": "2024-09-24",
"unanimous": null
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"full_restatement",
"targeted_amendment",
"legal_form_change",
"wvv_adaptation",
"name_change",
"object_change",
"duration_change",
"share_split",
"share_consolidation",
"share_class_creation",
"language_switch",
"warrant_exercise_capital_update",
"board_authorized_capital",
"governance_restructure",
"liquidation_preference_introduction",
"seat_region_change",
"other"
],
"scope": "full_restatement",
"trigger": "wvv_adaptation",
"language_after": "fr",
"language_before": "fr"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0479.292.440",
"name_full_after": "MDxHealth",
"legal_form_after": "Soci\u00E9t\u00E9 anonyme",
"name_full_before": "MDxHealth",
"current_zetel_raw": "Rue d\u0027Abhooz 31, 4040 Herstal",
"legal_form_before": "Soci\u00E9t\u00E9 anonyme"
},
"special_mandates": [
{
"holder_kbo": null,
"holder_name": "TD Securities (USA) LLC",
"scope_categories": [
"kbo"
],
"with_substitution": null
},
{
"holder_kbo": null,
"holder_name": "Genomic Health, Inc.",
"scope_categories": [
"kbo"
],
"with_substitution": null
}
],
"articles_modified": [
{
"summary": "Le capital est fix\u00E9 \u00E0 200.161.112,37 EUR, divis\u00E9 en 47.288.093 actions sans valeur nominale, enti\u00E8rement souscrit et lib\u00E9r\u00E9.",
"new_text": "Le capital s\u0027\u00E9l\u00E8ve \u00E0 deux cent millions cent soixante-et-un mille cent douze euros trente-sept cents (EUR 200.161.112,37). Il est divis\u00E9 en quarante-sept millions deux cent quatre-vingt-huit mille nonante-trois (47.288.093) actions sans valeur nominale, chacune repr\u00E9sentant la m\u00EAme fraction du capital. Le capital est enti\u00E8rement et inconditionnellement souscrit et est enti\u00E8rement lib\u00E9r\u00E9",
"change_kind": "replaced",
"article_title": null,
"article_number": "5.1"
},
{
"summary": "Ajout d\u0027une clause confirmant la r\u00E9alisation de l\u0027augmentation de capital de 35.858.359,48 EUR par l\u0027\u00E9mission de 20 millions d\u0027actions lib\u00E9r\u00E9es.",
"new_text": "Aux termes de l\u0027acte re\u00E7u par le notaire Stijn Raes, notaire de r\u00E9sidence \u00E0 Gent, le 27 septembre 2024, il a \u00E9t\u00E9 constat\u00E9 que l\u0027augmentation du capital, dans le cadre du capital autoris\u00E9, d\u00E9cid\u00E9e par le conseil d\u0027administration du 24 septembre 2024, a \u00E9t\u00E9 r\u00E9alis\u00E9e \u00E0 concurrence de trente-cinq millions huit cent cinquante-huit mille trois cent cinquante-neuf euros quarante-huit cents (EUR 35.858.35",
"change_kind": "added",
"article_title": null,
"article_number": "5.2"
},
{
"summary": "R\u00E9f\u00E9rence au Code des soci\u00E9t\u00E9s et des associations pour le paiement int\u00E9gral du montant de l\u0027augmentation de capital.",
"new_text": null,
"change_kind": "referenced",
"article_title": null,
"article_number": "7:198"
},
{
"summary": "R\u00E9f\u00E9rence au Code des soci\u00E9t\u00E9s et des associations pour le paiement int\u00E9gral du montant de l\u0027augmentation de capital.",
"new_text": null,
"change_kind": "referenced",
"article_title": null,
"article_number": "7:195"
},
{
"summary": "Application de la proc\u00E9dure sur les apports en nature du Code des soci\u00E9t\u00E9s et des associations pour l\u0027apport du prix d\u0027\u00E9mission en dollars am\u00E9ricains.",
"new_text": null,
"change_kind": "referenced",
"article_title": null,
"article_number": "7:197"
},
{
"summary": "Application de l\u0027article 7:178 du Code des soci\u00E9t\u00E9s et des associations pour que toutes les actions existantes et en circulation aient le m\u00EAme pair comptable arrondi \u00E0 EUR 4,233 par action.",
"new_text": null,
"change_kind": "referenced",
"article_title": null,
"article_number": "7:178"
}
],
"governance_change": null,
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Stijn RAES",
"org_rep_person_name": null
},
"co_filed_documents": [
"exp\u00E9dition de l\u0027acte",
"souscription",
"sousciription",
"statuts coordonn\u00E9s"
],
"shareholder_rights": null,
"voorwerp_change_summary": null,
"capital_structure_change": {
"operations": [
"share_cancellation",
"share_class_creation",
"capital_increase_cash",
"eigen_aandelen_inkoop",
"eigen_aandelen_vernietigen",
"wvv_capital_release"
],
"split_ratio": null,
"shares_after": 47288093,
"shares_before": null,
"capital_after_eur": 200161112.37,
"capital_before_eur": null,
"share_classes_after": [
{
"count": 47288093,
"label": "actions sans valeur nominale",
"rights_summary": "Les nouvelles actions ont les m\u00EAmes droits et avantages, et sont \u00E0 tous \u00E9gards pari passu, y compris en ce qui concerne les droits aux dividendes et aux distributions, avec les actions existantes et en circulation de la Soci\u00E9t\u00E9 au moment de leur \u00E9mission.",
"voting_per_share": null
}
]
},
"coordinated_text_lineage": null
}18-10-2024 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDxHealth"
},
"legal_form_change": {
"new": "Soci\u00E9t\u00E9 anonyme",
"old": "Soci\u00E9t\u00E9 anonyme",
"changed": false
}
}25-09-2024 7 bestuurders benoemd, 2 herbenoemd
- Michael K. McGarrity — Bestuurder
- Ahok BV — Bestuurder
- Hilde Windels — Bestuurder
- Qaly-Co Sàrl — Bestuurder
- Donnie M. Hardison Jr. — Bestuurder
- Regine Slagmulder — Bestuurder
- Eric Bednarski — Bestuurder
- Koen Hoffman — Bestuurder
Technische details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Koen Hoffman",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": null,
"name": "Ahok BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": true,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires d\u00E9cide de renouveler le mandat de Ahok BV, repr\u00E9sent\u00E9e par Koen Hoffman en tant que repr\u00E9sentant permanent, en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, pour une dur\u00E9e de deux ans, s\u0027\u00E9tendant jusqu\u0027\u00E0, et y compris, la cl\u00F4ture de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des ac",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2026"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Lieve Verplancke",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": null,
"name": "Qaly-Co BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": true,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires d\u00E9cide de renouveler le mandat de Qaly-Co BV, repr\u00E9sent\u00E9e par Lieve Verplancke en tant que repr\u00E9sentante permanente, en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, pour une dur\u00E9e de deux ans, s\u0027\u00E9tendant jusqu\u0027\u00E0, et y compris, la cl\u00F4ture de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinai",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2026"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Michael K. McGarrity",
"address": null,
"birth_date": null,
"profession": "Chief Executive Officer (CEO)",
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Le conseil d\u0027administration de la soci\u00E9t\u00E9 est donc maintenant compos\u00E9 de (1) Michael K. McGarrity, Chief Executive Officer (CEO), administrateur et administrateur d\u00E9l\u00E9gu\u00E9 (jusqu\u0027en 2026)",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2026"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Ahok BV",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Le conseil d\u0027administration de la soci\u00E9t\u00E9 est donc maintenant compos\u00E9 de (1) Michael K. McGarrity, Chief Executive Officer (CEO), administrateur et administrateur d\u00E9l\u00E9gu\u00E9 (jusqu\u0027en 2026), (2) Ahok BV, repr\u00E9sent\u00E9e par Koen Hoffman, administrateur et pr\u00E9sident du conseil d\u0027admin\u00EDstration (jusqu\u0027en 202",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2026"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Hilde Windels",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "Hilde Windels BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Le conseil d\u0027administration de la soci\u00E9t\u00E9 est donc maintenant compos\u00E9 de (1) Michael K. McGarrity, Chief Executive Officer (CEO), administrateur et administrateur d\u00E9l\u00E9gu\u00E9 (jusqu\u0027en 2026), (2) Ahok BV, repr\u00E9sent\u00E9e par Koen Hoffman, administrateur et pr\u00E9sident du conseil d\u0027admin\u00EDstration (jusqu\u0027en 202",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2025"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Qaly-Co S\u00E0rl",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Le conseil d\u0027administration de la soci\u00E9t\u00E9 est donc maintenant compos\u00E9 de (1) Michael K. McGarrity, Chief Executive Officer (CEO), administrateur et administrateur d\u00E9l\u00E9gu\u00E9 (jusqu\u0027en 2026), (2) Ahok BV, repr\u00E9sent\u00E9e par Koen Hoffman, administrateur et pr\u00E9sident du conseil d\u0027admin\u00EDstration (jusqu\u0027en 202",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2026"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Donnie M. Hardison Jr.",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Le conseil d\u0027administration de la soci\u00E9t\u00E9 est donc maintenant compos\u00E9 de (1) Michael K. McGarrity, Chief Executive Officer (CEO), administrateur et administrateur d\u00E9l\u00E9gu\u00E9 (jusqu\u0027en 2026), (2) Ahok BV, repr\u00E9sent\u00E9e par Koen Hoffman, administrateur et pr\u00E9sident du conseil d\u0027admin\u00EDstration (jusqu\u0027en 202",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2025"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Regine Slagmulder",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "Regine Slagmulder BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Le conseil d\u0027administration de la soci\u00E9t\u00E9 est donc maintenant compos\u00E9 de (1) Michael K. McGarrity, Chief Executive Officer (CEO), administrateur et administrateur d\u00E9l\u00E9gu\u00E9 (jusqu\u0027en 2026), (2) Ahok BV, repr\u00E9sent\u00E9e par Koen Hoffman, administrateur et pr\u00E9sident du conseil d\u0027admin\u00EDstration (jusqu\u0027en 202",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2025"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Eric Bednarski",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Le conseil d\u0027administration de la soci\u00E9t\u00E9 est donc maintenant compos\u00E9 de (1) Michael K. McGarrity, Chief Executive Officer (CEO), administrateur et administrateur d\u00E9l\u00E9gu\u00E9 (jusqu\u0027en 2026), (2) Ahok BV, repr\u00E9sent\u00E9e par Koen Hoffman, administrateur et pr\u00E9sident du conseil d\u0027admin\u00EDstration (jusqu\u0027en 202",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2025"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": null,
"filing_date": "2024-09-11",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2024-05-30",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDxHealth",
"legal_form": "Soci\u00E9t\u00E9 Anonyme",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Michael McGarrity",
"org_rep_person_name": null,
"person_role_at_subject": "Administrateur d\u00E9l\u00E9gu\u00E9"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}25-09-2024 1 bestuurder benoemd, 1 ontslagnemend
- Qaly-Co Sàrl — Administrator
- Qaly-Co BV — Administrator
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrator",
"person": {
"rrn": null,
"name": "Qaly-Co BV",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrator",
"person": {
"rrn": null,
"name": "Qaly-Co S\u00E0rl",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDxHealth"
}
}25-09-2024 2 herbenoemd
- Koen Hoffman — Bestuurder
- Lieve Verplancke — Bestuurder
Technische details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Koen Hoffman",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Ahok BV",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires d\u00E9cide de renouveler le mandat de Ahok BV, repr\u00E9sent\u00E9e par Koen Hoffman en tant que repr\u00E9sentant permanent, en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, pour une dur\u00E9e de deux ans, s\u0027\u00E9tendant jusqu\u0027\u00E0, et y compris, la cl\u00F4ture de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des ac"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Lieve Verplancke",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Qaly-Co S\u00E0rl",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires d\u00E9cide de renouveler le mandat de Qaly-Co BV, repr\u00E9sent\u00E9e par Lieve Verplancke en tant que repr\u00E9sentante permanente, en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, pour une dur\u00E9e de deux ans, s\u0027\u00E9tendant jusqu\u0027\u00E0, et y compris, la cl\u00F4ture de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinai"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDXHEALTH, EN ABREGE : MDXH",
"legal_form": "SA"
}
}11-09-2024 1 bestuurder benoemd, 1 ontslagnemend
- Dr. Sanford Jay Siegel — Bestuurder
- Dr. Lieve Verplancke — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Dr. Lieve Verplancke",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Qaly-Co S\u00E0rl",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-07-07",
"evidence_quote": "de prendre acte et d\u0027accepter la d\u00E9mission de Qaly-Co S\u00E0rl, repr\u00E9sent\u00E9e par sa repr\u00E9sentante permanente Dr. Lieve Verplancke, de son mandat d\u0027administrateur, ainsi que de tous ses autres mandats au sein, de la Soci\u00E9t\u00E9, avec effet au 7 juillet 2024."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Dr. Sanford Jay Siegel",
"address": null,
"birth_date": null
},
"effective_date": "2024-07-06",
"evidence_quote": "qu\u0027\u00E0 la suite de la vacance due \u00E0 la d\u00E9mission de Qaly-Co S\u00E0rl, repr\u00E9sent\u00E9e par sa repr\u00E9sentante permanente Dr. Lieve Verplancke, Dr. Sanford Jay Siegel, lequel \u00E9lit domicile au si\u00E8ge de la Soci\u00E9t\u00E9, est coopt\u00E9 en tant qu\u0027administrateur de la Soci\u00E9t\u00E9 avec effet imm\u00E9diat, avec la m\u00EAme r\u00E9mun\u00E9ration que"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDXHEALTH, EN ABREGE : MDXH",
"legal_form": "SA"
}
}11-09-2024 7 bestuurders benoemd, 1 ontslagnemend
- Dr. Sanford Jay Siegel — Bestuurder
- Michael K. McGarrity — Bestuurder
- Ahok BV — Bestuurder
- Hilde Windels — Bestuurder
- Donnie M. Hardison Jr. — Bestuurder
- Regine Slagmulder — Bestuurder
- Eric Bednarski — Bestuurder
- Qaly-Co Sàrl — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Qaly-Co S\u00E0rl",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_dissolution",
"subkind": null,
"via_org": {
"kbo": null,
"name": "Qaly-Co S\u00E0rl",
"address": null,
"country": null,
"legal_form": "S\u00E0rl"
},
"statutory": "statutair",
"compensated": null,
"effective_date": "2024-07-07",
"evidence_quote": "de prendre acte et d\u0027accepter la d\u00E9mission de Qaly-Co S\u00E0rl, repr\u00E9sent\u00E9e par sa repr\u00E9sentante permanente Dr. Lieve Verplancke, de son mandat d\u0027administrateur",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Dr. Sanford Jay Siegel",
"address": "si\u00E8ge de la Soci\u00E9t\u00E9",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "successor_conditional",
"via_org": null,
"statutory": "statutair",
"compensated": true,
"effective_date": null,
"evidence_quote": "Dr. Sanford Jay Siegel, lequel \u00E9lit domicile au si\u00E8ge de la Soci\u00E9t\u00E9, est coopt\u00E9 en tant qu\u0027administrateur de la Soci\u00E9t\u00E9 avec effet imm\u00E9diat",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2026"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": "Dr. Lieve Verplancke",
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Michael K. McGarrity",
"address": null,
"birth_date": null,
"profession": "Chief Executive Officer (CEO)",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "M. Michael K. McGarrity, Chief Executive Officer (CEO), administrateur et administrateur d\u00E9l\u00E9gu\u00E9 (jusqu\u0027en 2026)",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2026"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Ahok BV",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Ahok BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "Ahok BV, repr\u00E9sent\u00E9e par M. Koen Hoffman, administrateur et pr\u00E9sident du conseil d\u0027administration (jusqu\u0027en 2026)",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2026"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Hilde Windels",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Hilde Windels BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "Hilde Windels BV, repr\u00E9sent\u00E9e par Mme Hilde Windels, administrateur (jusqu\u0027en 2025)",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2025"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Donnie M. Hardison Jr.",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "M. Donnie M. Hardison Jr., administrateur (jusqu\u0027en 2025)",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2025"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Regine Slagmulder",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Regine Slagmulder BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "Regine Slagmulder BV, repr\u00E9sent\u00E9e par Dr. Regine Slagmulder, administrateur (jusqu\u0027en 2025)",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2025"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Eric Bednarski",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "Dr. Eric Bednarski, administrateur (jusqu\u0027en 2025)",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2025"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Liege",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-09-11",
"filing_date": "2024-07-06",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2024-07-06",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDxHealth",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Michael McGarrity",
"org_rep_person_name": null,
"person_role_at_subject": "CEO et personne d\u00E9l\u00E9gu\u00E9e \u00E0 la gestion journali\u00E8re"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}11-09-2024 1 bestuurder benoemd, 1 ontslagnemend
- Dr. Sanford Jay Siegel — Bestuurder
- Dr. Lieve Verplancke — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Dr. Lieve Verplancke",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Dr. Sanford Jay Siegel",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDxHealth"
}
}11-07-2024 Publicatie in het Belgisch Staatsblad — Diversen
Technische details
{
"stage": null,
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-07-11",
"filing_date": "2024-07-09",
"act_kind_objet": "DIVERS"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2024-06-20",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0479.292.440",
"name": "MDxHealth",
"role": "contributor",
"address": "Rue d\u0027Abhooz 31, 4040 Herstal, CAP Business Center, Zone Industrielle des Hauts-Sarts",
"is_foreign": false,
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": null,
"name": "Royalty \u0026 Credit Opportunities IV, LP",
"role": "recipient",
"address": null,
"is_foreign": true,
"legal_form": null,
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "OrbiMed Royalty \u0026 Credit Opportunities IV Offshore, LP",
"role": "recipient",
"address": null,
"is_foreign": true,
"legal_form": null,
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": null,
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDxHealth",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Stijn RAES",
"org_rep_person_name": null
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la soci\u00E9t\u00E9 anonyme MDxHealth a approuv\u00E9 l\u0027\u00E9mission de 2.000.000 d\u0027options d\u0027action et de 1.000.000 de warrants pour actions. Elle a \u00E9galement approuv\u00E9 l\u0027\u00E9mission de 1.243.060 warrants pour actions destin\u00E9s \u00E0 Royalty \u0026 Credit Opportunities IV, LP et OrbiMed Royalty \u0026 Credit Opportunities IV Offshore, LP.",
"co_filed_documents": [
"exp\u00E9dition de l\u0027acte",
"registre",
"liste de pr\u00E9sence",
"registre des votes",
"rapport du conseil d\u0027administration conform\u00E9ment aux articles 7:180 et 7:191 du Code des soci\u00E9t\u00E9s et associations",
"rapport du commissaire conform\u00E9ment aux articles 7:180 et 7:191 du Code des soci\u00E9t\u00E9s et associations",
"rapport du conseil d\u0027administration conform\u00E9ment aux articles 7:180, 7:191 et 7:193 du Code des soci\u00E9t\u00E9s et associations",
"rapport du commissaire conform\u00E9ment aux articles 7:180, 7:191 et 7:193 du Code des soci\u00E9t\u00E9s et associations"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "capital_shares"
}11-07-2024 Publicatie in het Belgisch Staatsblad — Diversen
Technische details
{
"stage": null,
"notary": {
"name": "Stijn RAES",
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-07-11",
"filing_date": "2024-07-09",
"act_kind_objet": "DIVERS"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-06-20",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0479.292.440",
"name": "MDxHealth",
"role": "other",
"address": "4040 Herstal, rue d\u0027Abhooz 31, CAP Business Center, Zone Industrielle des Hauts-Sarts",
"is_foreign": false,
"legal_form": "SA",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "OrbiMed Royalty \u0026 Credit Opportunities IV, LP",
"role": "recipient",
"address": null,
"is_foreign": true,
"legal_form": null,
"is_new_company": false,
"jurisdiction_country": "US"
},
{
"kbo": null,
"name": "OrbiMed Royalty \u0026 Credit Opportunities IV Offshore, LP",
"role": "recipient",
"address": null,
"is_foreign": true,
"legal_form": null,
"is_new_company": false,
"jurisdiction_country": "US"
}
],
"exchange_ratio": null,
"legal_articles": [
"7:180",
"7:191",
"7:193"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "\u00C9mission de 1.243.060 nouveaux droits de souscription pour actions (\u00AB warrants \u00BB) d\u0027OrbiMed, avec suppression du droit de pr\u00E9f\u00E9rence des actionnaires existants et des d\u00E9tenteurs de droits de souscription en circulation, en faveur d\u0027OrbiMed Royalty \u0026 Credit Opportunities IV, LP et OrbiMed Royalty \u0026 Credit Opportunities IV Offshore, LP.",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDxHealth",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Stijn RAES",
"org_rep_person_name": null
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la soci\u00E9t\u00E9 anonyme MDxHealth, si\u00E9geant \u00E0 Herstal, a approuv\u00E9 l\u0027\u00E9mission de 1.243.060 nouveaux warrants d\u0027OrbiMed, avec suppression du droit de pr\u00E9f\u00E9rence des actionnaires existants. Ces warrants, d\u0027une dur\u00E9e de cinq ans, sont attribu\u00E9s \u00E0 OrbiMed Royalty \u0026 Credit Opportunities IV, LP et \u00E0 sa filiale offshore, en vue d\u0027un financement strat\u00E9gique. L\u0027acte a \u00E9t\u00E9 notifi\u00E9 le 9 juillet 2024 et publi\u00E9 le 11 juillet 2024 au Moniteur belge.",
"co_filed_documents": [
"exp\u00E9dition de l\u0027acte",
"registre",
"liste de pr\u00E9sence",
"registre des votes",
"rapport du conseil d\u0027administration conform\u00E9ment aux articles 7:180 et 7:191 du Code des soci\u00E9t\u00E9s et associations",
"rapport du commissaire conform\u00E9ment aux articles 7:180 et 7:191 du Code des soci\u00E9t\u00E9s et associations",
"rapport du conseil d\u0027administration conform\u00E9ment aux articles 7:180, 7:191 et 7:193 du Code des soci\u00E9t\u00E9s et associations",
"rapport du commissaire conform\u00E9ment aux articles 7:180, 7:191 et 7:193 du Code des soci\u00E9t\u00E9s et associations"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "capital_shares"
}13-06-2024 7 bestuurders benoemd correctie
- Michael K. McGarrity — Bestuurder
- Koen Hoffman — Bestuurder
- Hilde Windels — Bestuurder
- Lieve Verplancke — Bestuurder
- Donnie M. Hardison Jr. — Bestuurder
- Regine Slagmulder — Bestuurder
- Eric Bednarski — Bestuurder
Technische details
{
"events": [
{
"kind": "decharge_granted",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Valiance Advisors LLP",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2024-02-15",
"evidence_quote": "Chaque administrateur d\u00E9cide de prendre acte et d\u0027accepter la d\u00E9mission de Valiance Advisors LLP, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent, M. Jan Pensaert, de son mandat d\u0027administrateur de la Soci\u00E9t\u00E9, avec effet au 15 f\u00E9vrier 2024.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Michael K. McGarrity",
"address": null,
"birth_date": null,
"profession": "Chief Executive Officer (CEO) et administrateur ex\u00E9cutif",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Le conseil d\u0027administration de la Soci\u00E9t\u00E9 est dor\u00E9navant compos\u00E9 de (1) M. Michael K. McGarrity, Chief Executive Officer (CEO) et administrateur ex\u00E9cutif (jusqu\u0027en 2026)",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2026"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Koen Hoffman",
"address": null,
"birth_date": null,
"profession": "administrateur ind\u00E9pendant et pr\u00E9sident du conseil d\u0027administration",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Ahok BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Le conseil d\u0027administration de la Soci\u00E9t\u00E9 est dor\u00E9navant compos\u00E9 de (2) Ahok BV, repr\u00E9sent\u00E9e par M. Koen Hoffman, administrateur ind\u00E9pendant et pr\u00E9sident du conseil d\u0027administration (jusqu\u0027en 2024)",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2024"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Hilde Windels",
"address": null,
"birth_date": null,
"profession": "administrateur ind\u00E9pendant",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Hilde Windels BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Le conseil d\u0027administration de la Soci\u00E9t\u00E9 est dor\u00E9navant compos\u00E9 de (3) Hilde Windels BV, repr\u00E9sent\u00E9e par Mme Hilde Windels, administrateur ind\u00E9pendant (jusqu\u0027en 2025)",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2025"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Lieve Verplancke",
"address": null,
"birth_date": null,
"profession": "Dr.",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Qaly-Co BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Le conseil d\u0027administration de la Soci\u00E9t\u00E9 est dor\u00E9navant compos\u00E9 de (4) Qaly-Co BV, repr\u00E9sent\u00E9e par Dr. Lieve Verplancke, administrateur ind\u00E9pendant (jusqu\u0027en 2024)",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2024"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Donnie M. Hardison Jr.",
"address": null,
"birth_date": null,
"profession": "administrateur ind\u00E9pendant",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Le conseil d\u0027administration de la Soci\u00E9t\u00E9 est dor\u00E9navant compos\u00E9 de (5) M. Donnie M. Hardison Jr., administrateur ind\u00E9pendant (jusqu\u0027en 2025)",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2025"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Regine Slagmulder",
"address": null,
"birth_date": null,
"profession": "Dr.",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Regine Slagmulder BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Le conseil d\u0027administration de la Soci\u00E9t\u00E9 est dor\u00E9navant compos\u00E9 de (6) Regine Slagmulder BV, repr\u00E9sent\u00E9e par Dr. Regine Slagmulder, administrateur ind\u00E9pendant (jusqu\u0027en 2025)",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2025"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Eric Bednarski",
"address": null,
"birth_date": null,
"profession": "Dr.",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Le conseil d\u0027administration de la Soci\u00E9t\u00E9 est dor\u00E9navant compos\u00E9 de (7) Dr. Eric Bednarski, administrateur non-ex\u00E9cutif (jusqu\u0027en 2025)",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2025"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Mam nt rianaturn fnae annlinahin m",
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-06-13",
"filing_date": "2024-04-03",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2024-04-03",
"unanimous": true
}
],
"is_correction": true,
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDxHealth",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Michael McGarrity",
"org_rep_person_name": null,
"person_role_at_subject": "CEO et personne d\u00E9l\u00E9gu\u00E9e \u00E0 la gestion journali\u00E8re"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}13-06-2024 Valiance Advisors LLP neemt ontslag als bestuurder
- Valiance Advisors LLP — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Valiance Advisors LLP",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0479.292.440",
"name_full": "MDxHealth"
}
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamFR | MDxHealth |
| AfkortingFR | MDxH |